A More-Precise CRISPR/Cas9

Researchers have refined amino acids in the Cas9 protein to reduce the occurrence of off-target gene edits.

By Karen Zusi | December 2, 2015

PIXABAY, PUBLICDOMAINPICTURESThe CRISPR/Cas9 system is already a widely used precision gene-editing tool, but a group of researchers from the Broad Institute of MIT and Harvard have engineered the Cas9 protein to make it even more efficient. By altering three of Cas9’s amino acids, researchers were able to significantly reduce the occurrence of off-target gene edits. The results were published yesterday (December 1) in Science.

“For therapeutic applications, we all want to proceed with maximum caution to make sure we’re not modifying the genome at undesired locations,” David Liu, a chemical biologist at Harvard University who was not involved with the work, told Nature.

Even with Cas9’s precision, the protein still sometimes made mistakes between the RNA that guides it and the DNA that it actually binds. The three edited amino acids, each with a positive ion charge, normally help Cas9 bind to DNA—which is negatively charged. Replacing these amino acids with alanine, which is neutral, hindered Cas9’s ability to bind off-target DNA sites without significantly affecting the correct edits. “It’s a matter of tempering the excess ‘enthusiasm’ of Cas9, so that it grudgingly accepts on-target sequences and nothing else,” Liu told Nature.

The engineered Cas9 is yet another step in refining the CRISPR/Cas9 gene-editing system, though some researchers are still cautious about its potential. “The field is advancing at a rapid pace, and there is still a lot to learn before we can consider applying this technology for clinical use,” study coauthor Feng Zhang said in a press release.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: Jay Griffin

Jay Griffin

Posts: 2

December 10, 2015

How long before it will be ready for clinical use?  From what I've read there are ethical issues that need to be addressed.  Also, there need to be a way to deliver the treatment to the patient, correct?



Popular Now

  1. Dartmouth Professor Investigated for Sexual Misconduct Retires
  2. Two University of Rochester Professors Resign in Protest
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Laxative Causes Long-Term Changes to Mouse Microbiome